Health
Calypta Health provides evidence-based digital guides and adaptive conversations that help patients make informed preventive care decisions about vaccines, screenings, and medications. Tested in preregistered randomized controlled trials, the platform generates clinical handoff briefs for providers, summarizing what moved the patient and what concerns remain. It serves health systems, insurers, public health agencies, and employers seeking measurable behavior change.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Funding
Founders
Product
Problem
People often delay or refuse screenings, vaccines, and preventive medications despite overwhelming evidence in their favor, leading to preventable deaths and billions in wasted healthcare spending. Fifteen-minute clinical appointments cannot adequately address patients' unanswered questions, fears, and misconceptions.
Solution
Calypta Health delivers evidence-based decision-support tools that combine clear, jargon-free content with patient, adaptive dialogue. These conversations meet people where they are, addressing specific questions and misconceptions in any language without judgment or time pressure. Each interaction generates a clinical handoff brief for providers, summarizing what moved the patient, what concerns remain, and what to focus on during follow-up. The platform was tested in preregistered randomized controlled trials, showing a statistically significant increase in vaccination intent—more than one point on a seven-point scale—compared to control.
Target Audience
Primary customers are health systems, healthcare providers, health insurers, public health agencies, and employers seeking to improve preventive care uptake and reduce downstream costs.
Features
- Interactive guides for flu, HPV, MMR, shingles vaccination, colorectal cancer screening, cholesterol prevention, GLP-1 medication initiation, and needle-fear support
- Patient, adaptive dialogue system that responds to individual concerns in any language with plain-language answers
- Clinical handoff briefs that summarize patient decision drivers and remaining concerns for providers
- Privacy-by-design architecture with no account required for end users
- Scalable deployment options for individual patients or entire panels through private invitations and analytics
- Behavior-change approach validated in preregistered randomized controlled trials with persistent effects